Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Optinose Inc (NQ: OPTN )

4.190 USD -0.050 (-1.18%)
Official Closing Price Updated: 4:23 PM EST, Jan 15, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Optinose Inc

< Previous 1 2 3 4 5 6 7 8 Next >
The Daily Biotech Pulse: FDA Approves Novartis Lung Cancer Drug, 2-Way Contest Emerging For Tetraphase Pharma, Dexcom To Join S&P 500
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks hitting ... 
Tags XERS ELAN GNMK
From Benzinga
The Week Ahead In Biotech: Smid-Cap Earnings News Flow Picks Up Pace
Biotech stocks started last weekon a strong note but the upward momentum slowed through the week. The week saw a slew of earnings ... 
Tags BMY MRSN AKBA
From Benzinga
Optinose to Report First Quarter 2020 Financial Results and Corporate Updates on May 7, 2020
From GlobeNewswire News Releases
Analysts Predict 51% Gains Ahead For The Holdings of IWC
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
The Daily Biotech Pulse: Milestone Pharma Flunks Late-Stage Study, CytomX Strikes Cancer Drug Collaboration, BARDA Grant For GenMark's COVID-19 Test
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit ... 
Tags SLS ADXN GSK
From Benzinga
Analysts Expect 50% Upside For IWV
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
The Daily Biotech Pulse: Mylan Ramps Up Manufacturing Of Potential COVID-19 Drug, Lexicon Stops Study Early, Masimo To Buy German Ventilation Company
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit ... 
Tags Covid/19 Trading Ideas NTUS
From Benzinga
The Daily Biotech Pulse: Pfizer's Eczema Drug Aces Latestage Study, Orphan Drug Designation For Dicerna, Dyadic's COVID-19 Connection
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags XCUR Top Stories SRDX
From Benzinga
The Daily Biotech Pulse: Setback For DBV In Peanut Allergy Patch Review, Roche Starts Coronavirus Test Shipment, Regeneron Aims For 'Cocktail' COVID-19 Treatment
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit ... 
Tags Guidance PCRX News
From Benzinga
Stocks That Hit 52-Week Lows On Monday
On Monday, 2568 stocks hit new 52-week lows. Areas of Significance: Amazon.com(NASDAQ: AMZN)is the largest company ... 
Tags MBCN SCS Forest Products
From Benzinga
OptiNose, Inc. (OPTN) Q4 2019 Earnings Call Transcript
OPTN earnings call for the period ending December 31, 2019. 
Tags Market News OPTN
From Motley Fool
The Daily Biotech Pulse: Trevana Pain Drug Resubmission Accepted For Review, Can-Fite To Explore Treatment For COVID-19
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags OPTN CODX CUE
From Benzinga
Optinose Reports Fourth Quarter and Full Year 2019 Financial Results and Recent Operational Highlights
From GlobeNewswire News Releases
The Week Ahead In Biotech: COVID-19 Stocks In The Spotlight, Earnings Taper Off
Biotech stocks came under significant weakness along with the broader market in the week ended Feb. 28. Despite fears the COVID-19 ... 
Tags URGN IPOs FGEN
From Benzinga
Optinose to Report Fourth Quarter and Full Year 2019 Financial Results and Corporate Updates on March 5, 2020
Conference Call and Webcast Scheduled for Thursday, March 5 at 7:30 a.m. Eastern Time 
From GlobeNewswire News Releases
Currax Pharmaceuticals Delivers Strong Operational and Financial Performance Eight Months into Operations
- Exceeded 2019 growth expectations, generating over $70M of revenue in eight months and substantial cash flow, enabling 30% debt reduction 
From PR Newswire
Investors Snatch OPTN 32.3% Cheaper Than Its Secondary Stock Offering
Looking back to 95 days ago, OptiNose Inc (OPTN) priced a 5,500,000 share secondary stock offering at $9.75 per share. Buyers in that offering made a considerable investment into the company, expecting... 
Tags Stocks
From Market News Video
Optinose Appoints Victor Clavelli as Chief Commercial Officer
From GlobeNewswire News Releases
OptiNose is Now Oversold (OPTN)
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a... 
Tags Stocks
From Market News Video
Sum Up The Parts: BIB Could Be Worth $73
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Land This Bargain Even Cheaper Than Director Scodari Did
There's an old saying on Wall Street about insider buying: there are many possible reasons to sell a stock, but only one reason to buy. Back on December 6, OptiNose Inc's Director, Joseph C.. 
Tags Stocks
From Market News Video
60 Biggest Movers From Friday
Gainers LAIX Inc. (NYSE: LAIX) shares jumped 85.5% to close at $7.68 on Friday. Marinus Pharmaceuticals Inc (NASDAQ: MRNS) ... 
Tags SHLO KRTX TXG
From Benzinga
Benzinga's Top Upgrades, Downgrades For December 18, 2019
Upgrades JP Morgan upgraded the stock for Alexandria Real Estate Equities Inc (NYSE: ARE) from Neutral to Overweight. For the ... 
Tags FBIO COLD ALLO
From Benzinga
IBB's Holdings Imply 18% Gain Potential
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Optinose Announces Peer-Reviewed Publication of the Fourth Major XHANCE Registration Trial
From GlobeNewswire News Releases
Optinose to Present at the Piper Jaffray 31st Annual Healthcare Conference
From GlobeNewswire News Releases
66 Biggest Movers From Yesterday
Gainers Stage Stores, Inc. (NYSE: SSI) shares surged 52% to close at $3.39 on Thursday after the company reported Q3 ... 
Tags TLRY APHA IPAR
From Benzinga
Here’s Why Shares of Optinose Crashed Today
A secondary offering resets the valuation of the ear, nose, and throat specialist. 
Tags Market News OPTN
From Motley Fool
45 Stocks Moving In Thursday's Mid-Day Session
Gainers Hepion Pharmaceuticals, Inc. (NASDAQ: HEPA) shares climbed 59.7% to $3.8650 after the thinly-traded, nano-cap biotech ... 
Tags LAIX JG Trading Ideas
From Benzinga
Optinose Announces Pricing of Public Offering of Common Stock
From GlobeNewswire News Releases
< Previous 1 2 3 4 5 6 7 8 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.